Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
Charlotte R. Grant, Rodrigo Liberal, Giorgina Mieli‐Vergani, et al.
Autoimmunity Reviews (2014) Vol. 14, Iss. 2, pp. 105-116
Open Access | Times Cited: 264

Showing 1-25 of 264 citing articles:

Human autoimmune diseases: a comprehensive update
Lifeng Wang, Fu‐Sheng Wang, M. Eric Gershwin
Journal of Internal Medicine (2015) Vol. 278, Iss. 4, pp. 369-395
Open Access | Times Cited: 938
Regulatory T Cells and Human Disease
Shimon Sakaguchi, Norihisa Mikami, James B. Wing, et al.
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 541-566
Closed Access | Times Cited: 830
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing, Atsushi Tanaka, Shimon Sakaguchi
Immunity (2019) Vol. 50, Iss. 2, pp. 302-316
Open Access | Times Cited: 586
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Christopher D. Spicer, Coline Jumeaux, Bakul Gupta, et al.
Chemical Society Reviews (2018) Vol. 47, Iss. 10, pp. 3574-3620
Open Access | Times Cited: 418
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders
Patrizia Fasching, Martin Stradner, W. Graninger, et al.
Molecules (2017) Vol. 22, Iss. 1, pp. 134-134
Open Access | Times Cited: 217
Immune senescence, epigenetics and autoimmunity
Donna Ray, Raymond Yung
Clinical Immunology (2018) Vol. 196, pp. 59-63
Open Access | Times Cited: 184
Metformin and Autoimmunity: A “New Deal” of an Old Drug
Francesco Ursini, Emilio Russo, Gianluca Pellino, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 181
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
Saskia J. Santegoets, Eveline M. Dijkgraaf, Alessandra Battaglia, et al.
Cancer Immunology Immunotherapy (2015) Vol. 64, Iss. 10, pp. 1271-1286
Open Access | Times Cited: 179
Modulation of regulatory T cell function and stability by co-inhibitory receptors
Liliana E. Lucca, Margarita Dominguez‐Villar
Nature reviews. Immunology (2020) Vol. 20, Iss. 11, pp. 680-693
Closed Access | Times Cited: 156
The Common Cytokine Receptor γ Chain Family of Cytokines
Jian‐Xin Lin, Warren J. Leonard
Cold Spring Harbor Perspectives in Biology (2017) Vol. 10, Iss. 9, pp. a028449-a028449
Open Access | Times Cited: 154
Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it?
Caroline Hull, Mark Peakman, Timothy Tree
Diabetologia (2017) Vol. 60, Iss. 10, pp. 1839-1850
Open Access | Times Cited: 149
Foxp3+ T Regulatory Cells: Still Many Unanswered Questions—A Perspective After 20 Years of Study
Ethan M. Shevach
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 137
Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action
Huajuan Jiang, Jie Li, Lin Wang, et al.
Journal of Ethnopharmacology (2020) Vol. 258, pp. 112913-112913
Closed Access | Times Cited: 137
What did we learn from CTLA‐4 insufficiency on the human immune system?
Noriko Mitsuiki, Charlotte Schwab, Bodo Grimbacher
Immunological Reviews (2018) Vol. 287, Iss. 1, pp. 33-49
Closed Access | Times Cited: 134
The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where
Ioannis S. Pateras, Sophia Havaki, Xenia Nikitopoulou, et al.
Pharmacology & Therapeutics (2015) Vol. 154, pp. 36-56
Open Access | Times Cited: 132
Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity
Mitesh Dwivedi, Prasant Kumar, Naresh C. Laddha, et al.
Autoimmunity Reviews (2016) Vol. 15, Iss. 4, pp. 379-392
Open Access | Times Cited: 129
Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease
Zbigniew Kmieć, Marta Cyman, Tomasz Ślebioda
Advances in Medical Sciences (2017) Vol. 62, Iss. 1, pp. 1-16
Closed Access | Times Cited: 120
B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab
Michèlle Rosenzwajg, Eva Languille, Hanna Dębiec, et al.
Kidney International (2017) Vol. 92, Iss. 1, pp. 227-237
Open Access | Times Cited: 117
Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway
Zhifeng Gu, Wei Tan, Juan Ji, et al.
Aging (2016) Vol. 8, Iss. 5, pp. 1102-1114
Open Access | Times Cited: 115
Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity
Themis Alissafi, Lydia Kalafati, Maria Lazari, et al.
Cell Metabolism (2020) Vol. 32, Iss. 4, pp. 591-604.e7
Open Access | Times Cited: 109
Regulatory T Cell-Derived TGF-β1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity
Jacob Turner, Emmanuel Stephen‐Victor, Sen Wang, et al.
Immunity (2020) Vol. 53, Iss. 6, pp. 1202-1214.e6
Open Access | Times Cited: 109
Cutting edge issues in autoimmune hepatitis
Rodrigo Liberal, Edward L. Krawitt, Simon C. Ling, et al.
Journal of Autoimmunity (2016) Vol. 75, pp. 6-19
Closed Access | Times Cited: 108
Co-morbidity of PTSD and immune system dysfunction: opportunities for treatment
Gretchen N. Neigh, Fariya F Ali
Current Opinion in Pharmacology (2016) Vol. 29, pp. 104-110
Open Access | Times Cited: 100
T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity
Roberto González‐Amaro, Mónica Marazuela
Endocrine (2015) Vol. 52, Iss. 1, pp. 30-38
Closed Access | Times Cited: 94
Nanoparticle-based autoimmune disease therapy
Pau Serra, Pere Santamaría
Clinical Immunology (2015) Vol. 160, Iss. 1, pp. 3-13
Closed Access | Times Cited: 91
Page 1 - Next Page

Scroll to top